KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OneSpan (OSPN) Research & Development (2016 - 2025)

OneSpan (OSPN) has disclosed Research & Development for 16 consecutive years, with $8.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 3.64% year-over-year to $8.0 million, compared with a TTM value of $34.2 million through Dec 2025, up 5.34%, and an annual FY2025 reading of $34.2 million, up 5.34% over the prior year.
  • Research & Development was $8.0 million for Q4 2025 at OneSpan, down from $8.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $12.9 million in Q2 2022 and bottomed at $7.5 million in Q3 2024.
  • Average Research & Development over 5 years is $9.8 million, with a median of $9.5 million recorded in 2023.
  • The sharpest move saw Research & Development grew 22.51% in 2021, then tumbled 30.52% in 2022.
  • Year by year, Research & Development stood at $11.7 million in 2021, then crashed by 30.52% to $8.1 million in 2022, then rose by 7.31% to $8.7 million in 2023, then dropped by 5.08% to $8.3 million in 2024, then decreased by 3.64% to $8.0 million in 2025.
  • Business Quant data shows Research & Development for OSPN at $8.0 million in Q4 2025, $8.8 million in Q3 2025, and $9.4 million in Q2 2025.